Samsung Biologics삼성바이오로직스
207940 · KOSPI · ₩SBL · 삼성바이오로직스
₩1,372,000▼ ₩2,000 (0.15%)End-of-day · Oct 28, 2026 · End-of-day prices.
Samsung Biologics207940· Biotech & PharmaUpdate note
Model Fair Value Estimate for Samsung Biologics Rises 22.9% to ₩580,299 Base Case
Our model estimate of fair value for Samsung Biologics moved up to a base case of ₩580,299 per share, from ₩472,202 in the previous report. The share price of ₩1,452,000 remains far above even the new bull case, so the change does not alter the gap between the model and the market.
Oct 27, 20260 views
Read the research reportReport history
- Oct 27, 2026Update noteModel fair value changeModel Fair Value Estimate for Samsung Biologics Rises 22.9% to ₩580,299 Base Case
- Oct 20, 2026Update noteBig price moveSamsung Biologics Shares Rise 18.8% in Five Days on Heavy Volume
- Oct 13, 2026InitiationSamsung Biologics: Profit Margins Have Expanded, but the Share Price Has Fallen Over the Past Three Months While Capital-Raising and Acquisition News Builds
This is not financial advice. The report does not recommend buying or selling anything.
Also known as: Samsung Biologics / 삼성바이오로직스 / 207940 / KRX:207940
Source: KRX statistical information